Evidence map›Paper›PMID 36036238›Full record

ArticleClinical and translational allergy2022

Mixed-methods evaluation of a nurse-led allergy clinic model in primary care: Feasibility trial.

Vicky Hammersley, Margaret Kelman, Lynn Morrice, Marilyn Kendall, Mome Mukerjhee, Susan Harley, Jurgen Schwarze, Aziz Sheikh

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Clinical and translational allergy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03826953 (Allergy UK Research and Development Nurse. Developing and Evaluating the Impact of a Nurse-led Primary Care-based Allergy Clinic in NHS Lothian), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03826953 nacompletednot on this map

Allergy UK Research and Development Nurse. Developing and Evaluating the Impact of a Nurse-led Primary Care-based Allergy Clinic in NHS Lothian: a Mixed Methods Pilot Study

TypeinterventionalSponsorUniversity of EdinburghRan2017 to 2021Enrolled250ConditionsAllergyArmsNurse Led Allergy Clinic
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Vicky HammersleyUsher Institute, University of Edinburgh, Edinburgh, UK.ORCID https://orcid.org/0000-0002-9854-3868
Margaret KelmanUsher Institute, University of Edinburgh, Edinburgh, UK.
Lynn MorriceHealth Data Research UK, London, UK.
Marilyn KendallUsher Institute, University of Edinburgh, Edinburgh, UK.
Mome MukerjheeUsher Institute, University of Edinburgh, Edinburgh, UK.
Susan HarleyUsher Institute, University of Edinburgh, Edinburgh, UK.
Jurgen SchwarzeChild Life and Health, Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK.
Aziz SheikhUsher Institute, University of Edinburgh, Edinburgh, UK.ORCID https://orcid.org/0000-0001-7022-3056
University of Edinburgh · GBCentre for Inflammation Research · GBHealth Data Research UK · GB

Funding

Allergy UK
6 · The paper itself

Abstract

introductionIt is now widely acknowledged that there are serious shortcomings in allergy care provision for patients seen in primary care. We sought to assess the feasibility of delivering and evaluating a new nurse-led allergy service in primary care, measured by recruitment, retention and estimates of the potential impact of the intervention on disease-specific quality of life.

methodsMixed-methods evaluation of a nurse-led primary care-based allergy clinic in Edinburgh, UK undertaken during the period 2017-2021 with a focus on suspected food allergy and atopic eczema in young children, allergic rhinitis in children and young people, and suspected anaphylaxis in adults. Prior to March 2020, patients were seen face-to-face (Phase 1). Due to COVID-19 pandemic restrictions, recruitment was halted between March-August 2020, and a remote clinic was restarted in September 2020 (Phase 2). Disease-specific quality of life was measured at baseline and 6-12 weeks post intervention using validated instruments. Quantitative data were descriptively analysed. We undertook interviews with 16 carers/patients and nine healthcare professionals, which were thematically analysed.

resultsDuring Phase 1, 426/506 (84%) referred patients met the eligibility criteria; 40/46 (87%) of Phase 2 referrals were eligible. Males and females were recruited in approximately equal numbers. The majority (83%) of referrals were for possible food allergy or anaphylaxis. Complete data were available for 338/426 (79%) patients seen in Phase 1 and 30/40 (75%) in Phase 2. Compared with baseline assessments, there were improvements in disease-specific quality of life for most categories of patients. Patients/carers and healthcare professionals reported high levels of satisfaction, this being reinforced by the qualitative interviews in which convenience and speed of access to expert opinion, the quality of the consultation, and patient/care empowerment were particularly emphasised.

conclusionThis large feasibility trial has demonstrated that it is possible to recruit, deliver and retain individuals into a nurse-led allergy clinic with both face-to-face and remote consultations. Our data indicate that the intervention was considered acceptable to patients/carers and healthcare professionals. The before-after data of disease-specific quality of life suggest that the intervention may prove effective, but this now needs to be confirmed through a formal randomised controlled trial.

trial registrationClinicalTrials.gov reference NCT03826953.

Indexed as

allergyprimary carequality of life

Identifiers

PMID36036238
PMCPMC9362986
OpenAlexW4290779820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.